380P Ten-year experience of the Vall d’Hebron Institute of Oncology early drug development unit (VHIO-UITM) treating patients (pts) with primary CNS tumours (pCNS)
| Autor: | Gonzalez, N. Saoudi, Villar, M. Vieito, Pedrazzoli, A.B. Azaro, Braña, I., Garcia-Alvarez, A., Montañá, F.J. Ros, Barcelo, R. Berchel, Gonzalez, M., Santa Gadea, O. Saavedra, Casal, G. Alonso, Galvao de Aguiar, V., Hernando-Calvo, A., Worham, N. Ann, Sole-Domenech, M., Sanchez, J. Llavall, Martinez-Ricarte, F., Saez, E. Martinez, Carles, J., Dienstmann, R., Garralda, E. |
|---|---|
| Zdroj: | In Annals of Oncology September 2020 31 Supplement 4:S403-S403 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|